Jones Hill Capital LP
Long book
$466.5M
Q1 2026
Positions
26
Top-10 weight
73%
concentration
Last quarter
+16.8%
SPY +14.8%
Turnover
—
of book per quarter
Strategy in plain words
auto-generated from filingsJones Hill Capital LP is a concentrated fundamental stock-picker, specialised in healthcare (100% of the long book), running a $466.5M US long book across 26 positions.
The portfolio is concentrated: the top 10 names carry 73% of the portfolio. Current anchor positions: BIOMARIN PHARMACEUTICAL INC, VERTEX PHARMACEUTICALS INC, VAXCYTE INC, NUVALENT INC-A, CAPRICOR THERAPEUTICS INC.
We rate its filings highest-signal: new buys here are worth attention.
Sector allocation
Healthcare 94%
Other 6%
Long book by quarter
What does Jones Hill own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 1.3M | $71.7M | 15.4% | Held |
| VRTX VERTEX PHARMACEUTICALS INC | Healthcare | 108.6K | $48.5M | 10.4% | Held |
| PCVX VAXCYTE INC | Healthcare | 644.8K | $37.5M | 8.0% | Held |
| NUVL NUVALENT INC-A | Healthcare | 300.8K | $30.8M | 6.6% | Held |
| CAPR CAPRICOR THERAPEUTICS INC | Healthcare | 909.2K | $27.6M | 5.9% | Held |
| 430 TERNS PHARMACEUTICALS INC | — | 521.2K | $27.5M | 5.9% | Held |
| BCAX BICARA THERAPEUTICS INC | Healthcare | 1.3M | $25.1M | 5.4% | Held |
| ANIP ANI PHARMACEUTICALS INC | Healthcare | 318.6K | $24.5M | 5.3% | Held |
| RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 1.2M | $24.4M | 5.2% | Held |
| ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 593.0K | $23.2M | 5.0% | Held |
| AMLX AMYLYX PHARMACEUTICALS INC | Healthcare | 1.6M | $22.2M | 4.8% | Held |
| FULC FULCRUM THERAPEUTICS INC | Healthcare | 1.8M | $13.6M | 2.9% | Held |
| VIR VIR BIOTECHNOLOGY INC | Healthcare | 1.2M | $10.7M | 2.3% | Held |
| NUVB NUVATION BIO INC | Healthcare | 2.4M | $10.2M | 2.2% | Held |
| ORKA ORUKA THERAPEUTICS INC | Healthcare | 140.8K | $6.9M | 1.5% | Held |
| CTNM CONTINEUM THERAPEUTICS INC-A | Healthcare | 513.1K | $6.7M | 1.4% | Held |
| MANE VERADERMICS INC | Healthcare | 100.8K | $6.4M | 1.4% | Held |
| TNXP TONIX PHARMACEUTICALS HOLDIN | Healthcare | 452.1K | $6.2M | 1.3% | Held |
| TRDA ENTRADA THERAPEUTICS INC | Healthcare | 374.0K | $4.7M | 1.0% | Held |
| PHVS PHARVARIS NV | Healthcare | 167.0K | $4.7M | 1.0% | Held |
| TRVI TREVI THERAPEUTICS INC | Healthcare | 370.2K | $4.4M | 0.9% | Held |
| RLMD RELMADA THERAPEUTICS INC | Healthcare | 342.8K | $2.4M | 0.5% | Held |
| AVBP ARRIVENT BIOPHARMA INC | Healthcare | 45.8K | $1.1M | 0.2% | Held |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 14, 2026 | 26 | $466.5M | canonical | SEC ↗ |